Sensitive and specific polymerase chain reaction assays for diagnosis of human T-cell lymphotropic virus type I (HTLV-I) and HTLV-II infections in HTLV-I/II-seropositive individuals

To confirm and differentiate between human T-cell lymphotropic virus type I (HTLV-I) and HTLV-II infections, we analyzed by polymerase chain reaction (PCR) samples of peripheral blood lymphocytes from 98 individuals seropositive for HTLV-I/II using pol (SK110/111) and tax (SK43/44) consensus primer pairs. A total of 96 samples (97.9%) were positive by the tax generic probe, while 95 were typed by the HTLV-I and HTLV-II pol probes. The three pol-negative samples were successfully amplified and typed by nested PCR with primers internal to SK110 and SK111. Results of PCR with a lysate of leukocyte nuclei obtained by whole blood lysis were comparable to those obtained with peripheral blood lymphocytes from 16 HTLV-seropositive subjects.

[1]  T. M. Hartley,et al.  Indeterminate HTLV serologic results in U.S. blood donors: are they due to HTLV-I or HTLV-II? , 1992, Journal of acquired immune deficiency syndromes.

[2]  T. M. Hartley,et al.  Synthetic peptide-based immunoassays for distinguishing between human T-cell lymphotropic virus type I and type II infections in seropositive individuals , 1991, Journal of clinical microbiology.

[3]  G. de Thé,et al.  In vivo genomic variability of human T-cell leukemia virus type I depends more upon geography than upon pathologies , 1991, Journal of virology.

[4]  S. Kleinman,et al.  Relative prevalence and risk factors of HTLV-I and HTLV-II infection in US blood donors , 1991, The Lancet.

[5]  H. McClure,et al.  Detection of occult simian immunodeficiency virus SIVsmm infection in asymptomatic seronegative nonhuman primates and evidence for variation in SIV gag sequence between in vivo- and in vitro-propagated virus , 1991, Journal of virology.

[6]  W. Heneine,et al.  HTLV-II endemicity among Guaymi Indians in Panama. , 1991, The New England journal of medicine.

[7]  W. Blattner,et al.  The epidemiology of the human T‐cell lymphotrophic virus type I and type II: etiologic role in human disease , 1991, Transfusion.

[8]  B. Hjelle,et al.  High frequency of human T-cell leukemia-lymphoma virus type II infection in New Mexico blood donors: determination by sequence-specific oligonucleotide hybridization. , 1990, Blood.

[9]  J. Giorgi,et al.  A clinical, hematologic, and immunologic analysis of 21 HTLV-II-infected intravenous drug users. , 1990, Blood.

[10]  S. Kwok,et al.  Low incidence of HTLV infections in random blood donors with indeterminate Western blot patterns , 1990, Transfusion.

[11]  S. Kwok,et al.  High prevalence of HTLV-II among intravenous drug abusers: PCR confirmation and typing. , 1990, AIDS research and human retroviruses.

[12]  J. Sninsky,et al.  Prevalence of human T-cell leukemia/lymphoma virus (HTLV) type II infection among high-risk individuals: type-specific identification of HTLVs by polymerase chain reaction. , 1989, Blood.

[13]  S. Kwok,et al.  Avoiding false positives with PCR , 1989, Nature.

[14]  J. Zack,et al.  High rate of HTLV-II infection in seropositive i.v. drug abusers in New Orleans. , 1989, Science.

[15]  S. Kwok,et al.  Characterization of a sequence of human T cell leukemia virus type I from a patient with chronic progressive myelopathy. , 1988, The Journal of infectious diseases.

[16]  J. Sninsky,et al.  Enzymatic gene amplification: qualitative and quantitative methods for detecting proviral DNA amplified in vitro. , 1988, The Journal of infectious diseases.